507 related articles for article (PubMed ID: 29970143)
21. Molecular and immunological characterization of a novel 32-kDa secreted protein of Babesia microti.
Ooka H; Terkawi MA; Cao S; Aboge G; Goo YK; Luo Y; Li Y; Nishikawa Y; Igarashi I; Xuan X
J Parasitol; 2012 Oct; 98(5):1045-8. PubMed ID: 22494017
[TBL] [Abstract][Full Text] [Related]
22. Serological diagnosis of human babesiosis by IgG enzyme-linked immunosorbent assay.
Loa CC; Adelson ME; Mordechai E; Raphaelli I; Tilton RC
Curr Microbiol; 2004 Dec; 49(6):385-9. PubMed ID: 15696612
[TBL] [Abstract][Full Text] [Related]
23. Elimination of
Skariah S; Arnaboldi P; Dattwyler RJ; Sultan AA; Gaylets C; Walwyn O; Mulhall H; Wu X; Dargham SR; Mordue DG
J Immunol; 2017 Jul; 199(2):633-642. PubMed ID: 28607116
[TBL] [Abstract][Full Text] [Related]
24. Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts.
Tuvshintulga B; Vannier E; Tayebwa DS; Gantuya S; Sivakumar T; Guswanto A; Krause PJ; Yokoyama N; Igarashi I
J Infect Dis; 2020 Aug; 222(6):1027-1036. PubMed ID: 32310272
[TBL] [Abstract][Full Text] [Related]
25. Roles of the Maltese cross form in the development of parasitemia and protection against Babesia microti infection in mice.
Yokoyama N; Bork S; Nishisaka M; Hirata H; Matsuo T; Inoue N; Xuan X; Suzuki H; Sugimoto C; Igarashi I
Infect Immun; 2003 Jan; 71(1):411-7. PubMed ID: 12496191
[TBL] [Abstract][Full Text] [Related]
26. Age-Related Differential Stimulation of Immune Response by
Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N
Front Immunol; 2018; 9():2891. PubMed ID: 30619263
[TBL] [Abstract][Full Text] [Related]
27. Recombinant methionine aminopeptidase protein of Babesia microti: immunobiochemical characterization as a vaccine candidate against human babesiosis.
Munkhjargal T; Yokoyama N; Igarashi I
Parasitol Res; 2016 Sep; 115(9):3669-76. PubMed ID: 27306898
[TBL] [Abstract][Full Text] [Related]
28. Human babesiosis: Indication of a molecular mimicry between thrombospondin domains from a novel Babesia microti BmP53 protein and host platelets molecules.
Mousa AA; Roche DB; Terkawi MA; Kameyama K; Kamyingkird K; Vudriko P; Salama A; Cao S; Orabi S; Khalifa H; Ahmed M; Attia M; Elkirdasy A; Nishikawa Y; Xuan X; Cornillot E
PLoS One; 2017; 12(10):e0185372. PubMed ID: 29040286
[TBL] [Abstract][Full Text] [Related]
29. Transmission risk evaluation of transfusion blood containing low-density
Cai Y; Xu B; Liu X; Yang W; Mo Z; Zheng B; Chen J; Hu W
Front Cell Infect Microbiol; 2024; 14():1334426. PubMed ID: 38375363
[TBL] [Abstract][Full Text] [Related]
30. Babesia microti: molecular and antigenic characterizations of a novel 94-kDa protein (BmP94).
Ooka H; Terkawi MA; Goo YK; Luo Y; Li Y; Yamagishi J; Nishikawa Y; Igarashi I; Xuan X
Exp Parasitol; 2011 Jan; 127(1):287-93. PubMed ID: 20599995
[TBL] [Abstract][Full Text] [Related]
31. Vaccination against babesiosis using recombinant GPI-anchored proteins.
Nathaly Wieser S; Schnittger L; Florin-Christensen M; Delbecq S; Schetters T
Int J Parasitol; 2019 Feb; 49(2):175-181. PubMed ID: 30684517
[TBL] [Abstract][Full Text] [Related]
32. Screening for Babesia microti in the U.S. Blood Supply.
Moritz ED; Winton CS; Tonnetti L; Townsend RL; Berardi VP; Hewins ME; Weeks KE; Dodd RY; Stramer SL
N Engl J Med; 2016 Dec; 375(23):2236-2245. PubMed ID: 27959685
[TBL] [Abstract][Full Text] [Related]
33. Babesia microti thioredoxin 3 is an effective antioxidant and involved in the response to antiprotozoal drugs.
Huang J; Xiong K; Zhang H; Zhao Y; Cao J; Zhou Y; Gong H; Zhou J
Ticks Tick Borne Dis; 2018 Mar; 9(3):645-653. PubMed ID: 29472160
[TBL] [Abstract][Full Text] [Related]
34. Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti.
Leiby DA; Chung AP; Gill JE; Houghton RL; Persing DH; Badon S; Cable RG
Transfusion; 2005 Nov; 45(11):1804-10. PubMed ID: 16271108
[TBL] [Abstract][Full Text] [Related]
35. Hematological findings and antibody responses in Syrian hamster (Mesocricetus auratus) infected with Babesia microti.
Ike K; Takeuchi K; Uchida Y; Imai S
J Vet Med Sci; 2005 Apr; 67(4):457-60. PubMed ID: 15876801
[TBL] [Abstract][Full Text] [Related]
36. Anti-Babesia microti antibodies in foresters highly exposed to tick bites in Poland.
Pancewicz S; Moniuszko A; Bieniarz E; Puciło K; Grygorczuk S; Zajkowska J; Czupryna P; Kondrusik M; Swierzbińska-Pijanowska R
Scand J Infect Dis; 2011 Mar; 43(3):197-201. PubMed ID: 21142620
[TBL] [Abstract][Full Text] [Related]
37. Utilization of a real-time PCR assay for diagnosis of Babesia microti infection in clinical practice.
Wang G; Wormser GP; Zhuge J; Villafuerte P; Ip D; Zeren C; Fallon JT
Ticks Tick Borne Dis; 2015 Apr; 6(3):376-82. PubMed ID: 25819568
[TBL] [Abstract][Full Text] [Related]
38. Analysis of antigen-antibody cross-reactivity among lineages and sublineages of Babesia microti parasites using human babesiosis specimens.
Sayama Y; Zamoto-Niikura A; Matsumoto C; Saijo M; Ishihara C; Matsubayashi K; Nagai T; Satake M
Transfusion; 2018 May; 58(5):1234-1244. PubMed ID: 29524239
[TBL] [Abstract][Full Text] [Related]
39. Primary Babesia rodhaini infection followed by recovery confers protective immunity against B. rodhaini reinfection and Babesia microti challenge infection in mice.
Wang G; Efstratiou A; Adjou Moumouni PF; Liu M; Jirapattharasate C; Guo H; Gao Y; Cao S; Zhou M; Suzuki H; Igarashi I; Xuan X
Exp Parasitol; 2016 Oct; 169():6-12. PubMed ID: 27423972
[TBL] [Abstract][Full Text] [Related]
40. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
